# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also rais...
Annual production over 500,000 ounces1Impressive margins with low AISC2 of ~$800/ozDrilling beyond PEA inventory shows high-gra...
Scotiabank analyst Tanya Jakusconek maintains Kinross Gold (NYSE:KGC) with a Sector Outperform and raises the price target f...
Kinross Gold (NYSE:KGC) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.13 by 30...
As gold prices rise, major miners face choices on how to best use their profits. Options include dividends, buybacks, explorati...
Top performers in last week: RIVN (+21.37%), EMPH (+21.15%), DHI (+12.53%), BLD (+12.15%), BIDU (+11.80%), GLW (+11.54%), INSM ...
Jefferies analyst Matthew Murphy maintains Kinross Gold (NYSE:KGC) with a Hold and raises the price target from $7 to $9.
CIBC analyst Anita Soni maintains Kinross Gold (NYSE:KGC) with a Outperformer and raises the price target from $8.15 to $12.